Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Keith Westby"'
Autor:
Sunil S. Patel, David R. Lally, Jason Hsu, Charles C. Wykoff, David Eichenbaum, Jeffrey S. Heier, Glenn J. Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M. Khanani
Publikováno v:
Eye.
Autor:
Sunil S. Patel, David R. Lally, Jason Hsu, Charles C. Wykoff, David Eichenbaum, Jeffrey S. Heier, Glenn J. Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M. Khanani
Publikováno v:
Eye.
Background/Objectives To assess the safety and efficacy of avacincaptad pegol (ACP), a C5 inhibitor, for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) over an 18-month treatment course. Subjects/Methods This study was an
Autor:
John Randolph, Harvey Masonson, Brian C. Joondeph, Keith Westby, Joel A. Pearlman, Sunil S. Patel, K.A. Rezaei, Karl G. Csaky, Glenn J. Jaffe, Jordi Monés
Publikováno v:
Ophthalmology. 128:576-586
Purpose The complement pathway may play a key role in the pathogenesis of age-related macular degeneration (AMD). The safety and efficacy of avacincaptad pegol (Zimura, IVERIC bio Inc, New York, NY), a C5 inhibitor, were assessed in participants with
Autor:
Glenn J. Jaffe, Keith Westby, Karl G. Csaky, Jordi Monés, Joel A. Pearlman, Sunil S. Patel, Brian C. Joondeph, John Randolph, Harvey Masonson, Kourous A. Rezaei
Publikováno v:
Ophthalmology. 128(12)
Autor:
Keith Westby, 韋司比
93
This is a case study attempted to determine the drivers in the outsourcing decisions of companies that have done substantial outsourcing of information systems and how they interpret the decision making from a transaction cost perspective in
This is a case study attempted to determine the drivers in the outsourcing decisions of companies that have done substantial outsourcing of information systems and how they interpret the decision making from a transaction cost perspective in
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/529v4d
Autor:
Glenn J. Jaffe, Keith Westby, Karl G. Csaky, Jordi Monés, Joel A. Pearlman, Sunil S. Patel, Brian C. Joondeph, John Randolph, Harvey Masonson, Kourous A. Rezaei
Publikováno v:
Ophthalmology. 128(5)
Autor:
Glenn J, Jaffe, Keith, Westby, Karl G, Csaky, Jordi, Monés, Joel A, Pearlman, Sunil S, Patel, Brian C, Joondeph, John, Randolph, Harvey, Masonson, Kourous A, Rezaei
Publikováno v:
Ophthalmology. 128(4)
The complement pathway may play a key role in the pathogenesis of age-related macular degeneration (AMD). The safety and efficacy of avacincaptad pegol (Zimura, IVERIC bio Inc, New York, NY), a C5 inhibitor, were assessed in participants with geograp
Publikováno v:
Ophthalmology Retina. 2:645-653
Real-world visual outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD) have been reported in cohorts outside of the United States. This study sought to assess the relationship
Autor:
Keith Westby, F. Devin, S. C. Patel, Glenn J. Jaffe, Harvey Masonson, Antonio P. Ciardella, Federico Ricci, Joel A. Pearlman, Pravin U. Dugel, Maddalena Quaranta-El Maftouhi, Chiara M. Eandi, Jordi Monés, Thomas A. Ciulla
Publikováno v:
Ophthalmology. 124:224-234
Purpose To assess the safety and efficacy of E10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, administered in combination with the anti–vascular endothelial growth factor (VEGF) agent ranibizumab (Luce
Autor:
Glenn J, Jaffe, Thomas A, Ciulla, Antonio P, Ciardella, Francois, Devin, Pravin U, Dugel, Chiara M, Eandi, Harvey, Masonson, Jordi, Monés, Joel A, Pearlman, Maddalena, Quaranta-El Maftouhi, Federico, Ricci, Keith, Westby, Samir C, Patel
Publikováno v:
Ophthalmology. 124(2)
To assess the safety and efficacy of E10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, administered in combination with the anti-vascular endothelial growth factor (VEGF) agent ranibizumab (Lucentis; Roch